Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumab.
Dominguez-Mozo MI, Perez-Perez S, Villar LM, Oliver-Martos B, Villarrubia N, Matesanz F, Costa-Frossard L, Pinto-Medel MJ, García-Sánchez MI, Ortega-Madueño I, Lopez-Lozano L, Garcia-Martinez A, Izquierdo G, Fernández Ó, Álvarez-Cermeño JC, Arroyo R, Alvarez-Lafuente R.
Dominguez-Mozo MI, et al. Among authors: lopez lozano l.
Sci Rep. 2020 Aug 28;10(1):14244. doi: 10.1038/s41598-020-71283-5.
Sci Rep. 2020.
PMID: 32859922
Free PMC article.